MRSH vs AJG vs AON
161 measures in 16 categories, one definition each, computed from filings and market data.
MRSH50.1
Marsh & McLennan Companies, Inc.
Financial Services · Insurance - Brokers
$188.35 +0.94%$89.9B mkt cap
Score DNA
AJG52.3
Arthur J. Gallagher & Co.
Financial Services · Insurance - Brokers
$254.88 +1.91%$65.3B mkt cap
Score DNA
Price, rebased to 100 three years ago
MRSH AJG AON · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 6 |
| Insider $ bought, 180d | — | — | $6.55M |
| Congress purchases, 180d | 2 | 5 | 0 |
| Last Congress purchase | 2026-06-02 | 2026-06-10 | — |
| 13F net change in holders | +1,507 | +48 | +10 |
| ETFs adding shares, 30d | 1,163 | 1,125 | 1,159 |
| ETFs trimming, 30d | 931 | 918 | 949 |
| Net ETF funds, 30d | +232 | +207 | +210 |
Valuation
16 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| P/E (TTM) | 22.2x
27th
|
41.6x
82nd
|
15.9x
0th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | — | 6.84
100th
|
1.32
50th
|
| Price / sales | 3.2x
46th
|
4.1x
77th
|
3.5x
62nd
|
| Price / book | 6.1x
64th
|
2.8x
9th
|
6.4x
73rd
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 21.6x
67th
|
28.6x
75th
|
19.1x
50th
|
| Price / operating cash flow | 20.1x
67th
|
26.7x
75th
|
17.6x
50th
|
| Enterprise value | $110.4B
100th
|
$66.0B
85th
|
$76.7B
92nd
|
| EV / sales | 3.9x
54th
|
4.2x
62nd
|
4.4x
69th
|
| EV / EBITDA | 18.3x
75th
|
16.5x
58th
|
11.4x
33rd
|
| EV / EBIT | 21.6x
73rd
|
24.8x
82nd
|
13.1x
9th
|
| EV / free cash flow | 26.6x
67th
|
28.8x
75th
|
23.6x
50th
|
| Earnings yield | 4.5%
77th
|
2.4%
31st
|
6.3%
100th
|
| FCF yield | 4.6%
38th
|
3.5%
31st
|
5.2%
54th
|
| Operating cash flow yield | 5.0%
38th
|
3.8%
31st
|
5.7%
54th
|
| Graham number (per share) | $76.26
67th
|
$111.85
78th
|
$135.93
89th
|
Profitability (TTM)
12 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Gross margin | 42.8%
38th
|
74.6%
77th
|
83.1%
92nd
|
| EBITDA margin | 21.2%
38th
|
25.4%
54th
|
38.3%
92nd
|
| Operating margin | 21.4%
62nd
|
17.0%
46th
|
27.2%
85th
|
| EBIT margin | 17.9%
54th
|
16.9%
46th
|
33.2%
92nd
|
| Net margin | 14.2%
69th
|
10.0%
54th
|
22.3%
100th
|
| NOPAT margin | 16.4%
54th
|
13.5%
38th
|
21.3%
77th
|
| FCF margin | 14.6%
46th
|
14.5%
38th
|
18.5%
77th
|
| Operating cash flow margin | 15.7%
46th
|
15.6%
38th
|
20.1%
69th
|
| R&D / revenue | 0.0%
0th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 0.0%
0th
|
35.7%
92nd
|
3.0%
25th
|
| Stock comp / revenue | 1.4%
42nd
|
0.3%
17th
|
1.8%
58th
|
| Effective tax rate | 23.3%
69th
|
20.6%
31st
|
21.7%
62nd
|
Returns on capital
11 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| ROE (on average equity) | 27.5%
73rd
|
6.7%
18th
|
44.7%
100th
|
| ROA | 6.8%
69th
|
1.9%
23rd
|
7.3%
77th
|
| ROIC | 13.3%
62nd
|
8.7%
38th
|
15.4%
85th
|
| ROCE | 13.5%
54th
|
6.9%
23rd
|
22.3%
77th
|
| Return on tangible assets | 8.5%
62nd
|
3.3%
15th
|
10.9%
69th
|
| Cash ROIC (OCF / invested capital) | 12.7%
36th
|
10.1%
27th
|
14.5%
55th
|
| Gross profitability (GP / assets) | 20.4%
31st
|
14.4%
15th
|
27.4%
54th
|
| ROIC, 3-yr average | — | 6.0%
22nd
|
13.0%
78th
|
| ROIC, 5-yr average | — | 7.0%
38th
|
20.3%
75th
|
| ROE, 5-yr average | — | 9.3%
12th
|
890.0%
100th
|
| Incremental ROIC | — | -7.8%
55th
|
-351.8%
9th
|
Growth
17 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Revenue growth (TTM YoY) | — | 26.3%
80th
|
4.9%
30th
|
| Revenue growth (QoQ) | -7.3%
31st
|
-15.9%
0th
|
-15.7%
8th
|
| Revenue CAGR, 3 yr | — | 19.6%
78th
|
10.9%
44th
|
| Revenue CAGR, 5 yr | — | 15.5%
62nd
|
8.4%
38th
|
| Gross profit CAGR, 3 yr | — | 44.5%
89th
|
32.7%
78th
|
| Operating income CAGR, 3 yr | — | 15.3%
38th
|
6.9%
25th
|
| Net income growth (TTM YoY) | — | -4.4%
22nd
|
50.4%
78th
|
| Net income CAGR, 3 yr | — | 12.1%
0th
|
13.5%
33rd
|
| EPS growth (TTM YoY) | — | -3.8%
22nd
|
52.3%
67th
|
| EPS CAGR, 3 yr | — | 6.1%
0th
|
12.0%
33rd
|
| EPS CAGR, 5 yr | — | 7.0%
43rd
|
14.7%
86th
|
| FCF growth (TTM YoY) | — | 16.0%
56th
|
11.5%
22nd
|
| FCF CAGR, 3 yr | — | 27.5%
50th
|
3.3%
0th
|
| Operating cash flow CAGR, 3 yr | — | 24.1%
75th
|
3.1%
0th
|
| Book value CAGR, 3 yr | — | 24.5%
50th
|
422.8%
100th
|
| Dividend CAGR, 3 yr | — | -0.5%
0th
|
1.7%
14th
|
| Sustainable growth rate | 15.3%
56th
|
3.7%
11th
|
37.2%
100th
|
Margin history & stability
7 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Gross margin, 3-yr average | — | 53.4%
67th
|
59.4%
78th
|
| Operating margin, 3-yr average | — | 19.1%
67th
|
25.6%
89th
|
| Net margin, 3-yr average | — | 11.2%
78th
|
18.6%
89th
|
| FCF margin, 3-yr average | — | 17.2%
56th
|
18.8%
78th
|
| Revenue stability (0-1) | — | 0.92
60th
|
0.92
70th
|
| Earnings stability (0-1) | — | 0.85
70th
|
0.68
40th
|
| Margin stability (0-1) | — | 0.68
30th
|
0.71
40th
|
Liquidity (latest quarter)
7 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Cash & short-term investments | $1.8B
100th
|
$1.4B
85th
|
$1.3B
77th
|
| Net cash (− = net debt) | −$20.5B
0th
|
−$631.0M
46th
|
−$14.6B
8th
|
| Working capital | $2.0B
85th
|
$2.3B
92nd
|
$888.0M
62nd
|
| Current ratio | 1.09
25th
|
1.05
8th
|
1.03
0th
|
| Quick ratio | 1.09
33rd
|
1.05
17th
|
1.03
0th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.08
17th
|
0.03
0th
|
0.05
8th
|
| Defensive interval (days) | 623 days
54th
|
301 days
23rd
|
722 days
69th
|
Leverage & solvency (latest quarter)
13 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Total debt | $22.3B
100th
|
$2.0B
54th
|
$15.9B
92nd
|
| Debt / equity | 1.52
73rd
|
0.09
18th
|
1.64
82nd
|
| Net debt / equity | 1.40
73rd
|
0.03
27th
|
1.51
82nd
|
| Debt / assets | 37.3%
77th
|
2.5%
8th
|
29.8%
46th
|
| Debt / capital | 60.3%
73rd
|
7.8%
18th
|
62.2%
82nd
|
| Debt / EBITDA | 3.71
75th
|
0.50
17th
|
2.36
25th
|
| Net debt / EBITDA | 3.40
83rd
|
0.16
17th
|
2.17
50th
|
| Interest coverage (EBIT / interest) | 5.2x
58th
|
4.1x
42nd
|
149.6x
83rd
|
| Cash interest coverage | 4.6x
33rd
|
3.8x
25th
|
90.5x
83rd
|
| Debt payback (years of OCF) | 5.0 yrs
75th
|
0.8 yrs
17th
|
4.5 yrs
67th
|
| Liabilities / assets | 75.1%
46th
|
71.0%
31st
|
81.8%
77th
|
| IS credit model rating | BBB | A+ | A |
| Implied credit spread (bps) | 275
62nd
|
125
15th
|
150
31st
|
Efficiency
11 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Asset turnover | 0.48
46th
|
0.19
0th
|
0.33
23rd
|
| Fixed asset turnover | 12.77
50th
|
11.73
42nd
|
11.63
33rd
|
| Inventory turnover | — | — | — |
| Receivables turnover | 3.7
15th
|
2.9
0th
|
3.4
8th
|
| Days sales outstanding | 99 days
85th
|
125 days
100th
|
106 days
92nd
|
| Days inventory outstanding | — | — | — |
| Days payables outstanding | 80 days
77th
|
0 days
0th
|
280 days
92nd
|
| Cash conversion cycle (days) | 18 days
31st
|
125 days
100th
|
−174 days
8th
|
| Capex / revenue | 1.1%
42nd
|
1.0%
33rd
|
1.6%
58th
|
| Capex / depreciation | 0.35
67th
|
0.12
25th
|
0.32
58th
|
| Operating expense ratio | 22.9%
46th
|
66.2%
69th
|
95.2%
100th
|
Cash flow & earnings quality
7 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Operating cash flow / net income | 1.11
9th
|
1.56
45th
|
0.90
0th
|
| FCF / net income | 1.03
18th
|
1.46
45th
|
0.83
0th
|
| FCF / operating cash flow | 92.8%
55th
|
93.3%
64th
|
92.0%
45th
|
| Capex / operating cash flow | 7.2%
45th
|
6.7%
36th
|
8.0%
55th
|
| Accruals ratio | -0.7%
92nd
|
-1.1%
85th
|
0.7%
100th
|
| Sloan accruals ratio | 1.5%
62nd
|
-17.7%
15th
|
-1.4%
54th
|
| Earnings quality score (0-1) | 1.00
64th
|
1.00
64th
|
0.75
0th
|
Scores & forensic checks
15 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| IS score | 50
38th
|
52
46th
|
50
31st
|
| IS profitability | 59
62nd
|
43
38th
|
69
92nd
|
| IS growth | — | 55
30th
|
65
60th
|
| IS value | 51
69th
|
45
46th
|
50
62nd
|
| IS momentum | — | 82
40th
|
77
30th
|
| IS risk (safety) | 100
31st
|
100
31st
|
100
31st
|
| IS quality | 62
31st
|
78
85th
|
69
54th
|
| IS balance sheet | 35
23rd
|
56
85th
|
42
31st
|
| IS earnings quality | 70
62nd
|
73
92nd
|
64
46th
|
| IS cash flow | 56
15th
|
78
100th
|
59
23rd
|
| Piotroski F-score (0-9) | 4
8th
|
7
62nd
|
8
92nd
|
| Altman Z-score | — | — | — |
| Beneish M-score | — | — | — |
| Ohlson O-score | −7.73
31st
|
−7.35
46th
|
−6.82
54th
|
| IS credit score | 56
38th
|
79
85th
|
74
69th
|
Size (TTM)
8 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| Market cap | $89.9B
100th
|
$65.3B
92nd
|
$62.1B
85th
|
| Revenue | $28.5B
100th
|
$15.8B
85th
|
$17.6B
92nd
|
| EBITDA | $6.0B
92nd
|
$4.0B
85th
|
$6.7B
100th
|
| Net income | $4.0B
100th
|
$1.6B
85th
|
$3.9B
92nd
|
| Free cash flow | $4.2B
100th
|
$2.3B
85th
|
$3.2B
92nd
|
| Total assets | $59.8B
92nd
|
$81.8B
100th
|
$53.3B
85th
|
| Shareholders' equity | $14.7B
92nd
|
$23.7B
100th
|
$9.7B
77th
|
| Employees | 95,000
100th
|
67,456
92nd
|
60,000
85th
|
Price performance
9 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| 1 day | +0.9% | +1.9% | +2.0% |
| 1 week | +7.1% | +9.5% | +7.0% |
| 1 month | +8.5% | +5.6% | −1.2% |
| 3 months | +4.0% | +0.5% | −19.2% |
| 6 months | +7.1% | +15.0% | −11.4% |
| Year to date | +3.7% | −0.4% | −14.4% |
| 1 year | — | −13.7% | −17.0% |
| 3 years, cumulative | — | +10.7% | −8.3% |
| 5 years, cumulative | — | +70.9% | +3.4% |
Technicals
4 measures| Measure | MRSH | AJG | AON |
|---|---|---|---|
| RSI 14 | 71.2 | 65.6 | 53.5 |
| From 52-week high | — | −11.4% | −23.3% |
| From 52-week low | — | +33.6% | +9.8% |
| Beta | 0.58 | 0.55 | 0.69 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17